Mayne Pharma (MYX AU): FY25 Results Aid Both Sides
At first glance, the results support Mayne's stance. However, the results provide Cosette with several angles to pursue to bolster its case of a...
651 Views
Weekly Deals Digest (24 Aug) - Mayne Pharma, PointsBet, Lynch, Dongfeng Motor, ENN Energy, Shibaura
A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
591 Views
Mayne Pharma (MYX AU): Got to Know when to Hold ‘em, when to Fold ’em
The near-term focus is on FY25 results on 29 August, which should provide incremental clarity, but not a definite answer, on the MAC breach. Risk...
786 Views
Merger Arb Mondays (11 Aug) - Mayne, PointsBet, Infomedia, Ashimori, Toyo Const, HKBN, Joy City
I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
839 Views
Mayne Pharma (MYX AU): Entering Uncharted Territory as the Scheme Vote Passes
While Western case law burdens the buyer with establishing a MAC breach, the Mayne/Cosette court case wades into uncharted territory, bringing many...
578 Views